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Summary: Macro enzymes, i. e. complexes of normal (iso-)enzymes with an immunoglobulin, may be due to
immunological cross-reactions evoked by specific viral antigenic determinants that are homologous to regions
in the target enzymes. A search of the National Biomedical Research Foundation protein databank with the
amino-acid sequence of human pancreatic amylase revealed a marked homology with a fragment of the yellow
fever virus major envelope protein E: i.e. an overall identity of 19.7 per cent and a high degree (40.9 per
cent) of conservative amino-acid substitutions over 119 amino acids. At each identical position, the corre-
sponding residue of Taka amylase A was examined by three-dimensional structure analysis, to determine
whether the position is likely to be buried or exposed. The existence of a site (epitope) on amylase recognized
by an anti-amylase antibody is discussed.
Introduction , ,macro enzymes (2, 3) to date, only macro amylase
Macro enzymes are enzymes in serum with a higher (EC 3.2.1.1), macro lactate dehydrogenase (EC
relative molecular mass (Mr) than the corresponding 1.1.1.27), and macro creatine kinase (EC 2.7.3.2)
enzyme normally present in serum under type 1 fulfill the above criteria.
(patho)physiological conditions. Macro enzymes are A 1 . . /. ^ . j . - t i /*· · r·„ , r Λ r \ -Λ A characteristic feature of individuals suffering fromusually complexes of normal (iso-)enzymes with an r , , · i. · * *i u ι· τ u i -r- j * one °f these three macro enzymes is the persistentimmunoglobulin. To be classified as a true macro r , Λ Δ . J , - i nι . f . . presence of the complex during the entire follow-upenzyme, a protein complex must satisfy certain en- ^ . . . ^ ,, . . ^. _. * , . rf - - , . - u period. This indicates an underlying chronic eventtena. First, a subunit of the complex should be an , . , . , . * ι · ι_ ι n- -u* u ·, , ,. ι ι ι · * · r ι . which m relation to the high prevalence of light chainimmunoglobulin. Second, the binding of the antigen . , , -, . , ι ι - ι υ ι ι ι ι 7 restriction is initiated and continued by a pathogenicto the immunoglobulin should take place by the for-
mation of non-covalent bounds between the antigen
and the antigen-binding region of the immunoglob- This raises the question of how these individuals are
ulin. Third, the antigen-antibody reaction should be stimulated to mount a strong chronic immune re-
reversible. Consequently, the law of mass action from sponse to the enzyme antigen. By molecular mimicry,
which the antibody affinity can be calculated is rele- an immune response to certain viral antigens may
vant. Finally, the antigen-antibody reaction should produce antibodies that cross-react with normal host
demonstrate specificity and a high level of affinity (1). antigens (5, 6); i.e. amylase, lactate dehydrogenase,
Of all the reported groups of immunoglobulin-bound and creatine kinase. Chemical similarity of amino-
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acid residues is a necessary, but not a sufficient, cri-
terion for antigenic similarity: secondary and tertiary
structures also make an important contribution to the
identities of epitopes. At this stage, information on
three-dimensional structure is available only for am-
ylase (7, 8). The current paper therefore describes the
results of a computer search, in which the sequence
of human pancreatic amylase was compared with
proteins of viruses known to infect humans. The cor-
responding positions with identity between residues
were determined in the three-dimensional structure of
Taka amylase A.
Methods
The amino-acid sequences of Taka amylase A (9) and porcine
pancreatic amylase (10) were aligned using available structural
information. The alignments were generated using the Brook-
haven program BESTFIT (11). Taka amylase A coordinates (7)
from the protein databank entry 2TAA (12) were analysed with
the program DSSP (13) to obtain positions of secondary struc-
tural elements. Secondary structural elements of porcine pan-
creatic amylase were assigned according to the study of Buisson
et al. (8). Sequences of human pancreatic amylase (14) and
porcine pancreatic amylase were aligned without deletions or
insertions.
Sequence comparisons between human pancreatic amylase and
the proteins in the NBRF protein databank (15) were performed
using the program FASTA (16). The statistical significance of
the alignments were assessed using a modification of the pro-
gram BESTFIT (11).
At positions where human pancreatic amylase and the yellow
fever virus major envelope protein E (17) were found to be
identical, the corresponding residue of Taka amylase A was
examined to determine whether the position is likely to be
buried or exposed. The structural analysis was performed with
the program FRODO (18).
The stereo drawings of the α-carbon backbone of the (α/β)8
barrel domain of Taka amylase A were generated using the
program ARTIPLOT (19).
Results
The availability of computer programs (11), designed
to search for homologous sequences, allowed us to
explore the possibility that at least one viral peptide
segment is sufficiently similar to a region in the target
human pancreatic amylase. As a result the NBRF
protein databank containing 13413 sequences with a
total of 3707414 residues showed an apparent se-
quence homology between the N-terminal parts of the
major envelope protein Ε of the yellow fever virus
(17) and human pancreatic amylase. The alignment
yielded 19.7 per cent sequence identity (standard de-
viation = 3.16), and 40.9 per cent conservative
amino-acid substitutions according to the Dayhoff
matrix (20) in a 119 amino-acid overlap. In figure 1
the aligned region of the yellow fever virus major
envelope protein Ε (genome polyprotein-yellow fever
virus, GNWVYP, 286 to 404, gene sequence number-
ing) is shown with the corresponding amino-acid res-
idues in human pancreatic amylase (HUMAMY),
porcine pancreatic amylase (PORAMY), and Taka
amylase A (TAKAMY). The structural elements cor-
responding to the latter two sequences are given in
lower case letters below the sequences (a: α-helix; g:
3 — 10 helix; : -strand). The alignment between the
yeast and the mammalian amylase yielded an 18 per
cent sequence identity and the sequences of human
pancreatic and porcine pancreatic amylase an 85 per
cent sequence identity.
At the positions where human pancreatic amylase and
the yellow fever virus major envelope protein E were
found to be identical, indicated by a straight vertical
line, a colon or an asterisk in figure 1, the correspond-
ing residues of Taka amylase A were examined to
determine whether the position is likely to be buried
or exposed. The structural analysis revealed that of
the 23 identical amino-acid residues, 15 residues were
exposed (straight vertical line), 6 residues buried (co-
lon), and two residues were identified at positions
where the structural homology between Taka amylase
A and porcine pancreatic amylase is poor (asterisk).
The exposed amino-acid residues of Taka amylase A,
corresponding to sequence identities between human
pancreatic amylase and the yellow fever virus major
envelope protein E, are indicated in the stereodrawing
of the α-carbon backbone structure of the (α/β)8 barrel
domain of Taka amylase A (fig. 2).
Discussion
In a recent review on macro enzymes Remaley &
Wilding (2) drew attention to the question: "Why do
antibodies to enzymes form?". It has been assumed
that the "antigen-driven theory" and the "dysregula-
tion of the immune tolerance theory" may partly
explain their occurrence. We would like to suggest a
further, related hypothesis that explains the published
data: i. e. the mechanism of molecular mimicry, which
could play an important role in the pathogenesis of
autoimmune reactions if similar structures of an in-
fectious agent and a host cell protein share antigenic
sites (5). In this context, viruses in particular have
already been discussed as a potential cause of autoim-
munity (21). Among all of the known amino acid
sequences, our investigation solely revealed one can-
didate bearing a region of significant sequence simi-
larity with a fragment of human pancreatic amylase:
i. e. the yellow fever virus major envelope protein E.
This new information is supported by the following
findings.
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Fig. 2. Ribbon representation of the α-carbon backbone structure of the (α/β)8 barrel domain of Taka amylase A (residues 1 to
380). The positions of the 15 exposed amino-acid residues (indicated by a straight vertical line in fig. 1) corresponding to
sequence identities between the yellow fever virus major envelope protein Ε and human pancreatic amylase are indicated
by residue number labels. The drawing was generated using the program ARTIPLOT (16).
Inspection of the sequence of the entire RNA genome
of the yellow fever virus reveals a single long open
reading frame of 10233 nucleotides, which could en-
code a polypeptide of 3411 amino acids. The struc-
tural proteins are found within the ammo-terminal
780 residues of this polyprotein. The sequence with a
19.5 per cent identity and a 40.9 per cent conservative
amino-acid substitution over 119 amino acids is a
part of the N-terminal sequence in the A domain of
the major envelope protein E. This result supports
the experimental data published by Zinkernagel et al.
(22) using transgenic mice expressing the cell mem-
brane associated glycoprotein of the vesicular sto-
matitis virus as a self-antigen. These transgenic mice
could only be induced by the vesicular stomatitis virus
to trigger autoantibodies if the self-antigen was a part
of the viral envelope protein.
A distinguishing feature is the localization of antigenic
determinants within the flavivirus envelope E protein
structure. The B domain, a separate structural region
of the E protein representing residues 309—403 and
structurally dependent upon the location of the 315 —
345 disulphide bridge, contains the important anti-
genic determinants involved in haemagglutination and
neutralization and thus induces immunological re-
sponses in the infected host (23).
Many viruses, particularly if persistent, are suspected
to be involved in triggering autoantibodies (5). This
persistent character is well documented by examples
of cross-reacting immunoglobulins, which are stably
maintained in the circulation of apparently healthy
persons. For example, Greco (24) noted three cases of
macro creatine kinase, type 1, stable over a period of
at least two years; Urdal et al. (25) in their classical
work reported a case in which macro amylase was
still present three years after its initial discovery; and
Weijers et al. (26) reported a case of macro lactate
dehydrogenase, which to date is still present after its
initial discovery in 1978.
A distinguishing feature of the above mentioned three
"classical" immunoglobulin-complex macro enzymes
is the light-chain restriction. The evidence of this study
suggests that an infection with the yellow fever virus
induces the observed phenomena. In this context, we
would like to point out that autoantibodies to these
enzymes do not appear to be curiosities, with no
particular diagnostic or prognostic value, but that
they reflect pathogenicity (27).
The first 400 or so amino-acid residues of both Taka
amylase A and porcine amylase fold into a eight-
stranded α/β barrel domain, a fold observed for 17
different enzyme structures so far, but no non-enzyme
structures (28). The sequence homology found be-
tween the yellow fever virus major envelope protein
Ε and human pancreatic amylase is limited to the first
119 amino-acid residues of the N-terminal sequence
of the latter. From the known folding pattern of Taka
amylase A, it was possible to identify 15 exposed
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positions corresponding to sequence identities be-
tween human pancreatic amylase and the yellow fever
virus major envelope protein E. These exposed resi-
dues are not biased over the entire surface of the
ribbon representation of Taka amylase A (fig. 2) but
located in a definite region forming a discontinuous
site of at least 15 amino-acid residues. Studies of
protein antigenicity (29) using three-dimensional X-
ray crystallographic data from antigen-antibody com-
plexes indicate that an epitope site consists of ap-
proximately 15 amino-acid residues on the surface of
the antigen which are in contact with the binding site
of the antibody molecule. Furthermore, we assume
that the definite region of the yellow fever virus en-
velope protein and the amylase has a similar 3d fold.
The 315 — 345 disulphide bridge of the envelope pro-
tein resembles the 28 — 86 disulphide bridge of human
amylase. This would support the notion that the two
regions have a locally similar tertiary structure.
The 119 amino-terminal amino acids of human pan-
creatic amylase and human salivary amylase are iden-
tical, except for position 4 (Pro —> Ser) and position
52 (Tyr —»His). These two positions do not participate
in the sequence identities between human pancreatic
amylase and the yellow fever virus major envelope
protein E. It is therefore not surprising that most
auto-antibodies of macro amylase complexes have
little specificity for either type of amylase (25, 30 —
32).
The active site of the enzymes containing the typical
eight-stranded α/β barrel structure is located in a cleft
within the N-terminal central domain, at the carboxy-
end of the -strands of the (α/β)8 barrel (8, 28). In
the molecular model a Taka amylase A the active site
is located after the third -strand (7). Thus, the active
site and the site (epitope) on amylase recognized by
the anti-amylase antibody are clearly separated. Con-
sistent with this observation are the data showing that
the autoantibodies were non-inhibitory towards the
amylase activity (33, 34).
Because of the limited number of sequences for viral
proteins in the computer library, the probability that
the correct protein has been sequenced is less than 10
percent. The assigned yellow fever virus is a member
of the family of Flaviviridae. The flaviviruses are class-
ified as a separate family based on the structure of
their genomes and on the replication strategies of
these viruses (35). The family consists at least 66
viruses, 29 of which have been associated with human
disease: i.e. give rise to persistent infection and
chronic illness. To further complicate matters, new
members are being recognized. In 1988 the virus now
called hepatitis C virus was identified. The viral nu-
cleic acid is a 10000 nucleotide RNA which best
resembles flaviviruses in its genome (36). As more
information becomes available on viral proteins, we
expect to find additional homologies. The homology
presented in this paper might be considered as a first
approximation to be involved in the field of the "clas-
sical" macro enzymes.
In accordance with this theory and as a means of
extending the hypothesis, collaborative projects of
systematic screening to identify specific viral antibod-
ies and antigens in individuals suffering from one of
these three macro enzymes are in progress.
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